AccScience Publishing / OR / Online First / DOI: 10.36922/OR026110016
Cite this article
16
Download
335
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Fortified trabeculae-like biomimetic bone-filling material organoids for repair of weight-bearing bone defects

Chong Yin1,2 Xingyu Wang2 Jing Zhang2 Yang Yu3 Linfeng Liu2 Hongqi Han2 Guilin Luo2 Zhuo Guo2 Yingying Luo2 Conghui Jiang2 Ye Tian4 Rui Pang2 Jingxiang Li2 Wei Chen5* Bing Yang6* Xundong Deng4* Bing Guo1,2* Guangrong Wang1,2*
Show Less
1 Department of Clinical Laboratory, Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China
2 Department of Laboratory Medicine, Translational Medicine Research Center, North Sichuan Medical College, Nanchong, Sichuan, China
3 Department of Medical and Nursing Science, International School, Krirk University, Bangkok, Thailand
4 Lab for Bone Metabolism, Xi’an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, Research Center for Special Medicine and Health Systems Engineering, NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi’an, Shaanxi, China
5 Xinjiang Hua Shidan Drug Research Co., Urumqi, Xinjiang, China
6 Department of Public Health, International School, Krirk University, Bangkok, Thailand
OR 2026, 2(2), 026110016 https://doi.org/10.36922/OR026110016
Received: 11 March 2026 | Revised: 5 June 2026 | Accepted: 11 June 2026 | Published online: 30 June 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Repairing critical-sized bone defects remains challenging, and many synthetic fillers trade mechanical stability against bioactivity. In this study, a novel bone tissue-filling material was designed and synthesized. Based on a previously described trabeculae‑like biomimetic bone-filling material (TBM), mammoth tusk dentin was incorporated into this material, which endowed it with enhanced mechanical properties. We designated this material as fortified TBM (FTBM). FTBM demonstrated favorable mechanical strength, biocompatibility, and sustained drug-release capacity, thereby improving osteogenesis. In addition, human mesenchymal stem cells were encapsulated within the scaffold, resulting in a cell-laden biomaterial. Its efficacy in repairing bone defects was superior to the original TBM. This high‑hardness bone-filling material offers a strategy to enhance the mechanical stability of trabeculae-like fillers, warranting evaluation in load-bearing models.

Graphical abstract
Keywords
Bone-filling material
Mammoth tusk dentin
Osteogenesis
Bone defect
Funding
This work was supported by the National Natural Science Foundation of China (82272436, 32371371), the Science and Technology Innovation Talent Program of Xinjiang Tianshan Talented Youth Top Talent Project, the Natural Science Foundation of Xinjiang Uygur Autonomous Region (2022D01F49), the Clinical Research Program of Affiliated Hospital of North Sichuan Medical College (2021LC008), the North Sichuan Medical College Innovation Team (Natural Science: CBYTD-2025A04), the Doctoral Research Startup Fund Project of the Affiliated Hospital of North Sichuan Medical College (BS10001, CBY19-QD01), and the Innovation and Entrepreneurship project of North Sichuan Medical College (XJ202510634159, XJ202510634155, XJ202510634157, XJ202510634153, XJ202510634151).
Conflict of interest
The authors declare no conflict of interest.
References
  1. Sparks DS, Saifzadeh S, Savi FM, et al. A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction. Nat Protoc. 2020;15(3):877-924. doi: 10.1038/s41596-019-0271-2
  2. Meng F, Yu Y, Yu J, et al. A trabeculae-like biomimetic bone-filling material as a potential cell-laden scaffold for bone defect treatment. Cell-Laden Scaffold Res. 2025;1(2):025040003. doi: 10.36922/OR025040003
  3. De La Vega RE, van Griensven M, Zhang W, et al. Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2. Sci Adv. 2022;8(7):eabl6242. doi: 10.1126/sciadv.abl6242
  4. Wang Z, Lv ZH, Cai XJ, et al. Sculpting the Future of Bone: The Evolution of Absorbable Materials in Orthopedics. Adv Mater. 2026;38(9):e2510848. doi: 10.1002/adma.202510848
  5. Yin C, Deng M, Yu J, et al. An Andrias davidianus derived composite hydrogel with enhanced antibacterial and bone repair properties for osteomyelitis treatment. Sci Rep. 2024;14(1):24626. doi: 10.1038/s41598-024-75997-8
  6. Salamanca E, Hsu C, Huang H, et al. Bone regeneration using a porcine bone substitute collagen composite in vitro and in vivo. Sci Rep. 2018;8(1):984. doi: 10.1038/s41598-018-19629-y
  7. Zhang J, Zhang W, Yue W, Qin W, Zhao Y, Xu G. Research Progress of Bone Grafting: A Comprehensive Review. Int J Nanomed. 2025;20:4729-4757. doi: 10.2147/IJN.S510524
  8. Gui X, Peng W, Xu X, et al. Synthesis and application of nanometer hydroxyapatite in biomedicine. Nanotechnol Rev. 2022;11(1):2154-2168. doi: 10.1515/ntrev-2022-0127
  9. Dec P, Modrzejewski A, Pawlik A. Existing and novel biomaterials for bone tissue engineering. Int J Mol Sci. 2023;24(1):529. doi: 10.3390/ijms24010529
  10. Duan H, Cao C, Wang X, et al. Magnesium-alloy rods reinforced bioglass bone cement composite scaffolds with cortical bone-matching mechanical properties for load-bearing bone in vivo regeneration. Sci Rep. 2020;10(1):18193. doi: 10.1038/s41598-020-75328-7
  11. Xu Y, Sheng L, Zhu M, et al. From niche to organoid: Engineering bone tissues through microenvironmental insights. J Tissue Eng. 2025;16:1-25. doi: 10.1177/20417314251358567
  12. Lin S, Narayanan K, Vashishth D. Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes. Adv Sci. 2026;38:e2518788. doi: 10.1002/advs.202518788
  13. Wei HP, Cui JJ, Lin KL, et al. Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration[J]. Bone Res. 2022,10(1):58. doi: 10.1038/s41413-021-00180-y
  14. Taherian MH, Le TA, Le AVT, et al. Controlled microstructural evolution of hydroxyapatite–Bioglass® nanocomposites via two-step sintering. J Mech Behav Biomed Mater. 2026;175:107329. doi: 10.1016/j.jmbbm.2025.107329
  15. Arantes Fernandes Vieira L, Marinho JPN, de Sousa RG, et al. Development of a composite based on hydroxyapatite, carboxymethyl cellulose, and boron nitride nanotubes as a potential material for bone graft. ACS Appl Eng Mater. 2025;3(11):3964-3975. doi: 10.1021/acsaenm.5c00679
  16. Qi L, Zhao T, Yan J, et al. Advances in magnesium-containing bioceramics for bone repair. Biomater Transl. 2024;5(1):3-20. doi: 10.12336/biomatertransl.2024.01.002
  17. Liang J, Lu X, Zheng X, et al. Modification of titanium orthopedic implants with bioactive glass: a systematic review of in vivo and in vitro studies. Front Bioeng Biotechnol. 2023;11:1269223. doi: 10.3389/fbioe.2023.1269223
  18. Mani N, Sola A, Trinchi A, Fox K. Is there a future for additive manufactured titanium bioglass composites in biomedical application? A perspective. Biointerphases. 2020;15(6):068501. doi: 10.1116/6.0000557
  19. Fu Q, Saiz E, Rahaman MN, et al. Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl. 2011;31(7):1245-1256. doi: 10.1016/j.msec.2011.04.022
  20. Oliver-Urrutia C, Kashimbetova A, Slámečka K, et al. Porous titanium/hydroxyapatite interpenetrating phase composites with optimal mechanical and biological properties for personalized bone repair. Biomater Adv. 2025;166:214079. doi: 10.1016/j.bioadv.2024.214079
  21. Shen M, Lu Z, Xu Y, et al. Vivianite and its oxidation products in mammoth ivory and their implications to the burial process. ACS Omega. 2021;6(34):22284–22291. doi: 10.1021/acsomega.1c02964
  22. van der Valk T, Pečnerová P, Díez-Del-Molino D, et al. Million-year-old DNA sheds light on the genomic history of mammoths. Nature. 2021;591(7849):265-269. doi: 10.1038/s41586-021-03224-9
  23. Zhao L, Li X, Zhao J, et al. A novel smart injectable hydrogel prepared by microbial transglutaminase and human-like collagen: its characterization and biocompatibility. Mater Sci Eng C Mater Biol Appl. 2016;68(1):317-326. doi: 10.1016/j.msec.2016.05.108
  24. Tian Y, Zhao Y, Yin C, et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release. 2022;345:20-37. doi: 10.1016/j.jconrel.2022.03.003
  25. Hu L, Su P, Li R, et al. Knockdown of microtubule actin crosslinking factor 1 inhibits cell proliferation in MC3T3-E1 osteoblastic cells. BMB Rep. 2015;48(10):583-588. doi: 10.5483/bmbrep.2015.48.10.098
  26. Liu G, Wang L, He Y, et al. Polydopamine nanosheets doped injectable hydrogel with nitric oxide release and photothermal effects for bacterial ablation and wound healing. Adv Healthc Mater. 2021;10(23):e2101476. doi: 10.1002/adhm.202101476
  27. Hu L, Yin C, Chen D, et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ. 2021;28(7):2160-2178. doi: 10.1038/s41418-021-00744-9
  28. Li K, Chen Y, Lin Y, et al. PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice. Mol Ther. 2023;31(1):174-192. doi: 10.1016/j.ymthe.2022.09.006
  29. Ushiku C, Adams DJ, Jiang X, et al. Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. J Orthop Res. 2010;28(10):1338-1347. doi: 10.1002/jor.21105
  30. Yin C, Tian Y, Li D, et al. Long noncoding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. iScience. 2022;25(3):103949. doi: 10.1016/j.isci.2022.103949
  31. Wang X, Tian Y, Liang X, et al. Bergamottin promotes osteoblast differentiation and bone formation via activating the Wnt/β-catenin signaling pathway. Food Funct. 2022;13(5):2913-2924. doi: 10.1039/d1fo02755g
  32. Chen Z, Zhao F, Liang C, et al. Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuli. Theranostics. 2020;10(26):12263-12278. doi: 10.7150/thno.53009
  33. Kuczkowski M, Kotwica K. Biocompatible thermoplastics in additive manufacturing of bone defect fillers: state-of-the-art and future prospects. Materials. 2025;18(16):3723. doi: 10.3390/ma18163723
  34. Naini A, Rachmawati D, Cholid Z, et al. Enhanced osteogenic marker expression in alveolar bone via hydroxyapatite gypsum puger-cassava starch scaffold: an in vivo study. J Indian Prosthodont Soc. 2025;25(3):258-265. doi: 10.4103/jips.jips_97_25
  35. Fernandez de Grado G, Keller L, Idoux-Gillet Y, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9:2041731418776819. doi: 10.1177/2041731418776819
  36. Pérez-Lloret M, Erxleben A. Improved and highly reproducible synthesis of methacrylated hyaluronic acid with tailored degrees of substitution. ACS Omega. 2024;9(24):25914-25921. doi: 10.1021/acsomega.4c00372
  37. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147. doi: 10.1126/science.284.5411.143
  38. Lee M, Jeong SY, Ha J, et al. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo. Biochem Biophys Res Commun. 2014;446(4):983-989. doi: 10.1016/j.bbrc.2014.03.0510
Share
Back to top
Organoid Research, Electronic ISSN: 3082-8503 Published by AccScience Publishing